Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/1998
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/19/1998US5753611 Pharmaceutical composition having site-specific delivery
05/19/1998US5753230 Methods and compositions useful for inhibition of angiogenesis
05/19/1998US5753218 Administering interleukin-10 and steroid
05/19/1998CA2007507C Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020110A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
05/14/1998WO1998020040A1 Novel histamine h2 receptor
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019706A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998WO1998019683A1 Synergistic gold-containing compositions
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998CA2270922A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998CA2270909A1 Novel histamine h2 receptor
05/14/1998CA2270561A1 Synergistic gold-containing compositions
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/13/1998EP0841064A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840787A2 A human edg-2 receptor homolog
05/13/1998EP0840738A1 Colchicine derivatives, the use thereof and formulations containing them
05/13/1998EP0840735A1 Resolution of 1-azabicyclo 2.2.2]octan-3-amine, 2-(diphenylmethyl)-n- 2-methoxy-5-(1-methylethyl)phenyl]methyl]
05/13/1998EP0840732A1 Substituted benzolactam compounds as substance p antagonists
05/13/1998EP0840728A1 Heteroaryl diol acids as leukotriene antagonists
05/13/1998EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
05/13/1998EP0840615A2 Chemokine binding protein and methods of use therefor
05/13/1998EP0840606A1 Di- and trivalent small molecule selectin inhibitors
05/13/1998EP0525002B1 2[5H]-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca 2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS
05/13/1998CN1181783A Medical composition
05/13/1998CN1181761A Antigen compsn. against mycoplasma
05/13/1998CN1181753A Novel substituted piperazine derivatives having tachyknin receptor antagonists activity
05/13/1998CN1181706A Arteriovenous and venous graft treatments: methods and compsns.
05/13/1998CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/12/1998US5750706 Azepanes and their ring homologues having protein kinase inhibiting activity
05/12/1998US5750693 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
05/12/1998US5750573 Guanylhydrazones and their use to treat inflammatory conditions
05/12/1998US5750564 Anti-oxidant esters of non-steroidal anti-inflammatory agents
05/12/1998US5750560 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
05/12/1998US5750559 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
05/12/1998US5750555 Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino acid as PKC inhibitors
05/12/1998US5750546 2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof
05/12/1998US5750543 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/12/1998US5750539 Antiasthmatics
05/12/1998US5750518 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation and rheumatoid arthritis
05/12/1998US5750398 Vector, element and method for inhibiting immune recognition
05/12/1998US5750351 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
05/12/1998US5750139 Contained in inner space between impermeable top layer and microporous membrane welded togather
05/12/1998US5750125 Containing dibenzyl monosorbitol acetal and a refractory material
05/07/1998WO1998018921A1 NEUTROKINE $g(a)
05/07/1998WO1998018823A1 Ice inhibiting peptides
05/07/1998WO1998018796A1 Naphthyridine derivatives
05/07/1998WO1998018785A1 Substituted oximes derivatives useful as neurokinin antagonists
05/07/1998WO1998018761A1 Substituted arylalkylamines as neurokinin antagonists
05/07/1998WO1998018759A1 Vitamin d analogues
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018479A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
05/07/1998WO1998018468A1 Synergistic composition comprising rapamycin and calcitriol
05/07/1998WO1998018466A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
05/07/1998WO1998018464A1 Substituted tricyclics
05/07/1998WO1998018461A1 Integrin antagonists
05/07/1998WO1998009985A3 Anti-inflammatory peptides and uses thereof
05/07/1998WO1998007855A3 Secreted proteins and polynucleotides encoding them
05/07/1998WO1998006248A3 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN
05/07/1998CA2665133A1 Neutrokine .alpha.
05/07/1998CA2270373A1 Synergistic composition comprising rapamycin and calcitriol
05/07/1998CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2269203A1 Substituted tricyclics
05/06/1998EP0839806A1 Substituted tricyclics
05/06/1998EP0839529A2 Compositions containing aliphatic monocarboxylic acid esters or amides for the treatment of skin diseases
05/06/1998EP0839052A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases
05/06/1998EP0839046A1 Tnf receptor and steroid hormone in a combined therapy
05/06/1998EP0839042A1 Bacterial inhibition with an oligosaccharide compound
05/06/1998EP0839041A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts
05/06/1998EP0839039A1 Paroxetine controlled release compositions
05/06/1998EP0817636A4 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis
05/06/1998EP0745072B1 4-amino derivatives of 5-substituted mycophenolic acid
05/06/1998EP0740652B1 Metalloproteinase inhibitors
05/06/1998EP0738270B1 Dihydro pyrazolopyrroles
05/06/1998EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
05/06/1998CN1181075A Substituted isoxazoles for the treatment of inflammation
05/06/1998CN1181073A 1, 3 -dihydro -2H -imidazol -2 -one derivatives having PDEIV and cytokinin inhibiting activity
05/06/1998CN1181072A 1, 3 -dihydro -1 -(phenylalkyl) -2H -imdiazol- 2 -one derivatives having PDEIV and cytokine activity
05/06/1998CN1181071A 1, 3-dihydro -1 -(phonylalkenyl) -2H -imidazol -2 -one derivatives having PDEIV and cytokine inhibiting activity
05/06/1998CN1181066A Arylsulfonylamino hydroxamic acid derivatives
05/06/1998CN1181018A 多功能酶 Multifunctional enzyme
05/06/1998CN1180520A Compound capsule for treating red swollen and heat-evil due to wind-cold-dampness
05/05/1998US5747664 N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives
05/05/1998US5747639 Use of hydrophobic interaction chromatography to purify polyethylene glycols
05/05/1998US5747514 Metalloproteinase inhibitors
05/05/1998US5747506 Antihistamines, bronchodilator agents; asthma
05/05/1998US5747499 Cyclopentaquinazoline compounds cyclopentaquinazoline compounds
05/05/1998US5747491 Morpholine derivatives and their use as antagonists of tachikinins
05/05/1998US5747489 Arylalkyl-thiadiazinones
05/05/1998US5747481 Analgesics and antiinflammaory agents
05/05/1998US5747462 Pharmaceutically active compounds and their use
05/05/1998US5747458 Plasminogen activator of protease and tripeptides
05/05/1998US5747457 Linear adhesion inhibitors
05/05/1998US5747318 Mitogen activated c-Fos regulating kinase, FRK
05/05/1998US5747061 Suspension of loteprednol etabonate for ear, eye, or nose treatment
1 ... 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 ... 1272